Lee Troy Schalop - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Lee Troy Schalop has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $100K.
Profile
Lee Troy Schalop holds the role of Director at Lantern Pharma Inc. (LTRN). Schalop has reported 3 insider filings with the SEC since 2025. The most recent filing was in May 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- Lantern Pharma Inc.
Reported roles
- Director
Awards & honors
- Director of Lantern Pharma Inc. (as of 2026-05-14)
Trading Pattern
InsiderAlpha's records for Lee Troy Schalop go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. The typical open-market purchase is $50K (2 buys totaling $100K). The largest single buy on record is $100K of LTRN in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Lee Troy Schalop has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at Lantern Pharma Inc. (LTRN) - 3 filings, 2025 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | LTRN | Lantern Pharma Inc. | P - Open-market purchase | 48.5K | $2.06 | $100K |
Companies - Last 90 Days
- Lantern Pharma Inc. (LTRN) - 1 filing, last 2026-05-14
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Lee Troy Schalop has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- D. Jeffrey Keyser - $100K of LTRN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Sam Levinson
- Paul S. Levy
- Liberty 77 Capital L.P.
- LIBERTY MUTUAL HOLDING CO
- Alfred Lin
- Lincoln Financial Investments Corp
- LINCOLN NATIONAL LIFE INSURANCE CO /IN/
- Adam C. Lipson
Frequently Asked Questions
Who is Lee Troy Schalop?
Lee Troy Schalop holds the role of Director at Lantern Pharma Inc. (LTRN). Schalop has reported 3 insider filings with the SEC since 2025. The most recent filing was in May 2026.…
How many SEC Form 4 filings has Lee Troy Schalop submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Lee Troy Schalop been buying or selling stock?
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
Where can I see all of Lee Troy Schalop's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Lee Troy Schalop profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.